$HSTO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Histogen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Histogen Inc.. Get notifications about new insider transactions in Histogen Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | HSTO | Histogen Inc. | Pascoe Richard W | President, CEO & Di ... | Buy | P | 1.14 | 20,000 | 22,800 | 30,000 | 10 K to 30 K (+200.00 %) |
| Mar 26 2021 | HSTO | Histogen Inc. | Fuhrmann Rochelle | Director | Option Exercise | A | 1.27 | 30,000 | 38,100 | 30,000 | |
| Mar 12 2021 | HSTO | Histogen Inc. | Windham-Bannister Susan Richar ... | Director | Option Exercise | A | 1.23 | 30,000 | 36,900 | 30,000 | |
| Jan 15 2021 | CNAT | Histogen Inc. | Pascoe Richard W | President, CEO & Di ... | Option Exercise | A | 0.97 | 346,000 | 335,620 | 346,000 | |
| Jan 15 2021 | CNAT | Histogen Inc. | Naughton Gail K | See Remarks | Option Exercise | A | 0.97 | 95,000 | 92,150 | 95,000 | |
| Jan 15 2021 | CNAT | Histogen Inc. | Latterich Martin | SVP, Technical Oper ... | Option Exercise | A | 0.97 | 90,000 | 87,300 | 90,000 | |
| Jan 15 2021 | CNAT | Histogen Inc. | Knudson Susan A. | EVP, CFO & Corp Sec ... | Option Exercise | A | 0.97 | 112,000 | 108,640 | 112,000 | |
| Jan 15 2021 | CNAT | Histogen Inc. | Daniels Moya | See Remarks | Option Exercise | A | 0.97 | 100,000 | 97,000 | 100,000 | |
| Dec 07 2020 | CNAT | Histogen Inc. | Pascoe Richard W | President, CEO & Di ... | Buy | P | 1.24 | 10,000 | 12,394 | 10,000 | 0 to 10 K |
| Oct 09 2020 | CNAT | Histogen Inc. | Zhang Yizhuo | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Oct 09 2020 | CNAT | Histogen Inc. | Satz Brian | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Oct 09 2020 | CNAT | Histogen Inc. | Mento Steven J | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Oct 09 2020 | CNAT | Histogen Inc. | KISNER DANIEL L | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Oct 09 2020 | CNAT | Histogen Inc. | Jackson Jonathan | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Oct 09 2020 | CNAT | Histogen Inc. | Crean David Hugh | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Oct 09 2020 | CNAT | Histogen Inc. | Chang Stephen | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| May 29 2020 | CNAT | Histogen Inc. | Knudson Susan A. | See Remarks | Option Exercise | A | 4.61 | 124,119 | 572,189 | 124,119 | |
| May 28 2020 | CNAT | Histogen Inc. | Pascoe Richard W | See Remarks | Option Exercise | J | 5.30 | 194,071 | 1,028,576 | 194,071 | |
| May 28 2020 | CNAT | Histogen Inc. | Pascoe Richard W | See Remarks | Option Exercise | J | 5.30 | 291,107 | 1,542,867 | 291,107 | |
| May 28 2020 | CNAT | Histogen Inc. | Naughton Gail K | See Remarks | Option Exercise | J | 0.53 | 380,063 | 201,433 | 380,063 | |
| May 28 2020 | CNAT | Histogen Inc. | Naughton Gail K | See Remarks | Buy | J | 0.00 | 426,526 | 0 | 426,526 | 0 to 426.5 K |
| May 28 2020 | CNAT | Histogen Inc. | Satz Brian | Director | Option Exercise | J | 3.84 | 35,855 | 137,683 | 35,855 | |
| May 28 2020 | CNAT | Histogen Inc. | Satz Brian | Director | Buy | J | 0.00 | 1,434 | 0 | 1,434 | 0 to 1.4 K |
| May 28 2020 | CNAT | Histogen Inc. | Latterich Martin | See Remarks | Option Exercise | J | 3.84 | 14,342 | 55,073 | 14,342 | |
| May 28 2020 | CNAT | Histogen Inc. | Latterich Martin | See Remarks | Option Exercise | J | 3.70 | 28,684 | 106,131 | 28,684 | |
| May 28 2020 | CNAT | Histogen Inc. | Latterich Martin | See Remarks | Buy | J | 0.00 | 11,951 | 0 | 11,951 | 0 to 12 K |
| May 28 2020 | CNAT | Histogen Inc. | Jackson Jonathan | Director | Buy | J | 0.00 | 2,356,597 | 0 | 2,356,597 | 0 to 2.4 M |
| May 28 2020 | CNAT | Histogen Inc. | Chang Stephen | Director | Option Exercise | J | 3.84 | 35,855 | 137,683 | 35,855 | |
| May 28 2020 | CNAT | Histogen Inc. | Chang Stephen | Director | Option Exercise | J | 1.47 | 14,342 | 21,083 | 14,342 | |
| May 28 2020 | CNAT | Histogen Inc. | Chang Stephen | Director | Buy | J | 0.00 | 14,485 | 0 | 14,485 | 0 to 14.5 K |
| May 28 2020 | CNAT | Histogen Inc. | Zhang Yizhuo | Director | Buy | J | 0.00 | 600,983 | 0 | 600,983 | 0 to 601 K |
| May 28 2020 | CNAT | Histogen Inc. | Crean David Hugh | Director | Option Exercise | J | 3.84 | 35,855 | 137,683 | 35,855 | |
| May 28 2020 | CNAT | Histogen Inc. | Crean David Hugh | Director | Option Exercise | J | 3.84 | 4,302 | 16,520 | 4,302 | |
| May 28 2020 | CNAT | Histogen Inc. | Crean David Hugh | Director | Option Exercise | J | 3.70 | 17,210 | 63,677 | 17,210 | |
| May 27 2020 | CNAT | Histogen Inc. | Marshall Keith W | EVP, COO & CFO | Option Exercise | M | 0.00 | 38,500 | 0 | 0 | |
| May 27 2020 | CNAT | Histogen Inc. | Marshall Keith W | EVP, COO & CFO | Payment of Exercise | F | 0.56 | 18,615 | 10,424 | 19,885 | 38.5 K to 19.9 K (-48.35 %) |
| May 27 2020 | CNAT | Histogen Inc. | Marshall Keith W | EVP, COO & CFO | Buy | M | 0.00 | 38,500 | 0 | 38,500 | 0 to 38.5 K |
| May 27 2020 | CNAT | Histogen Inc. | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | M | 0.00 | 31,343 | 0 | 0 | |
| May 27 2020 | CNAT | Histogen Inc. | Spada Alfred P. | EVP, R&D and CSO | Payment of Exercise | F | 0.56 | 12,960 | 7,258 | 19,595 | 32.6 K to 19.6 K (-39.81 %) |
| May 27 2020 | CNAT | Histogen Inc. | Spada Alfred P. | EVP, R&D and CSO | Buy | M | 0.00 | 31,343 | 0 | 32,555 | 1.2 K to 32.6 K (+2,586.06 %) |
| May 27 2020 | CNAT | Histogen Inc. | Mento Steven J | Director | Option Exercise | M | 0.00 | 65,000 | 0 | 0 | |
| May 27 2020 | CNAT | Histogen Inc. | Mento Steven J | Director | Payment of Exercise | F | 0.56 | 31,428 | 17,600 | 39,572 | 71 K to 39.6 K (-44.26 %) |
| May 27 2020 | CNAT | Histogen Inc. | Mento Steven J | Director | Buy | M | 0.00 | 65,000 | 0 | 71,000 | 6 K to 71 K (+1,083.33 %) |
| Nov 19 2019 | CNAT | Conatus Pharmaceut ... | Scott Kathleen D. | Director | Option Exercise | A | 0.33 | 30,000 | 9,900 | 30,000 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | A | 0.00 | 86,375 | 0 | 86,375 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 2.00 | 50,000 | 100,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 5.17 | 16,000 | 82,720 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 4.21 | 23,000 | 96,830 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 2.09 | 20,000 | 41,800 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 1.85 | 3,750 | 6,938 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 1.85 | 15,000 | 27,750 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 6.40 | 15,000 | 96,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 9.45 | 15,000 | 141,750 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 9.61 | 15,000 | 144,150 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | A | 0.00 | 313,436 | 0 | 313,436 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 2.00 | 175,000 | 350,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 5.17 | 70,000 | 361,900 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 4.21 | 100,625 | 423,631 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 1.85 | 21,875 | 40,469 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 1.85 | 109,375 | 202,344 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 6.40 | 100,000 | 640,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 9.45 | 50,000 | 472,500 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | A | 0.00 | 385,000 | 0 | 385,000 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | D | 2.00 | 175,000 | 350,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | D | 5.17 | 70,000 | 361,900 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | D | 5.74 | 525,000 | 3,013,500 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 0.00 | 650,000 | 0 | 650,000 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 2.00 | 350,000 | 700,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 5.17 | 120,000 | 620,400 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 4.21 | 172,500 | 726,225 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 1.85 | 37,500 | 69,375 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 1.85 | 20,000 | 37,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 6.40 | 50,000 | 320,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 6.40 | 150,000 | 960,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 9.45 | 400,000 | 3,780,000 | 0 | |
| Jul 01 2019 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | A | 0.29 | 20,000 | 5,800 | 20,000 | |
| Jul 01 2019 | CNAT | Conatus Pharmaceut ... | LARUE WILLIAM R | Director | Option Exercise | A | 0.29 | 20,000 | 5,800 | 20,000 | |
| Jul 01 2019 | CNAT | Conatus Pharmaceut ... | Klassen Preston | Director | Option Exercise | A | 0.29 | 20,000 | 5,800 | 20,000 | |
| Jul 01 2019 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 0.29 | 20,000 | 5,800 | 20,000 | |
| Jul 01 2019 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | A | 0.29 | 45,000 | 13,050 | 45,000 | |
| Feb 11 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | A | 2.00 | 175,000 | 350,000 | 175,000 | |
| Feb 11 2019 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 2.00 | 175,000 | 350,000 | 175,000 | |
| Jun 25 2018 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | A | 4.99 | 20,000 | 99,800 | 20,000 | |
| Jun 25 2018 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | A | 4.99 | 20,000 | 99,800 | 20,000 | |
| Jun 25 2018 | CNAT | Conatus Pharmaceut ... | LARUE WILLIAM R | Director | Option Exercise | A | 4.99 | 20,000 | 99,800 | 20,000 | |
| Jun 25 2018 | CNAT | Conatus Pharmaceut ... | Klassen Preston | Director | Option Exercise | A | 4.99 | 20,000 | 99,800 | 20,000 | |
| Jun 25 2018 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 4.99 | 20,000 | 99,800 | 20,000 | |
| Jun 25 2018 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | A | 4.99 | 45,000 | 224,550 | 45,000 | |
| May 07 2018 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | M | 0.99 | 60,000 | 59,400 | 147,070 | |
| May 07 2018 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Buy | M | 0.99 | 60,000 | 59,400 | 60,000 | 0 to 60 K |
| Mar 01 2018 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | M | 1.24 | 12,121 | 15,030 | 0 | |
| Mar 01 2018 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Buy | M | 1.24 | 12,121 | 15,030 | 12,121 | 0 to 12.1 K |
| Feb 05 2018 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | A | 5.17 | 16,000 | 82,720 | 16,000 | |
| Feb 05 2018 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | A | 5.17 | 70,000 | 361,900 | 70,000 | |
| Feb 05 2018 | CNAT | Conatus Pharmaceut ... | Smith Edward F III | SVP, Reg Affairs an ... | Option Exercise | A | 5.17 | 40,000 | 206,800 | 40,000 | |
| Feb 05 2018 | CNAT | Conatus Pharmaceut ... | Smith Edward F III | SVP, Reg Affairs an ... | Grant | A | 3.48 | 4,461 | 15,524 | 4,461 | 0 to 4.5 K |
| Feb 05 2018 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | A | 5.17 | 70,000 | 361,900 | 70,000 | |
| Feb 05 2018 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 5.17 | 70,000 | 361,900 | 70,000 | |
| Feb 05 2018 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 5.17 | 120,000 | 620,400 | 120,000 | |
| Sep 01 2017 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | A | 5.74 | 525,000 | 3,013,500 | 525,000 | |
| Jun 26 2017 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | A | 4.96 | 20,000 | 99,200 | 20,000 | |
| Jun 26 2017 | CNAT | Conatus Pharmaceut ... | Klassen Preston | Director | Option Exercise | A | 4.96 | 20,000 | 99,200 | 20,000 | |
| Jun 26 2017 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 4.96 | 20,000 | 99,200 | 20,000 | |
| Jun 26 2017 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | A | 4.96 | 20,000 | 99,200 | 20,000 | |
| Jun 26 2017 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | A | 4.96 | 45,000 | 223,200 | 45,000 | |
| Feb 07 2017 | CNAT | Conatus Pharmaceut ... | LARUE WILLIAM R | Director | Option Exercise | A | 5.09 | 30,000 | 152,700 | 30,000 | |
| Feb 02 2017 | CNAT | Conatus Pharmaceut ... | RIPLEY DANIEL L. | SVP, Bus Dev, P&A M ... | Option Exercise | A | 4.21 | 73,000 | 307,330 | 73,000 | |
| Feb 01 2017 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | A | 4.21 | 100,625 | 423,631 | 100,625 | |
| Feb 01 2017 | CNAT | Conatus Pharmaceut ... | Smith Edward F III | SVP, Reg Affairs an ... | Option Exercise | A | 4.21 | 57,500 | 242,075 | 57,500 | |
| Feb 01 2017 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 4.21 | 100,625 | 423,631 | 100,625 | |
| Feb 01 2017 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Option Exercise | A | 4.21 | 57,500 | 242,075 | 57,500 | |
| Feb 01 2017 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 4.21 | 172,500 | 726,225 | 172,500 | |
| Jan 11 2017 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Option Exercise | M | 0.99 | 42,424 | 42,000 | 0 | |
| Jan 11 2017 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Buy | M | 0.99 | 42,424 | 42,000 | 42,424 | 0 to 42.4 K |
| Dec 30 2016 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Buy | J | 0.00 | 2,310 | 0 | 5,455 | 3.1 K to 5.5 K (+73.45 %) |
| Dec 22 2016 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | M | 0.99 | 5,051 | 5,000 | 207,070 | |
| Dec 22 2016 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | M | 1.24 | 36,363 | 45,090 | 0 | |
| Dec 22 2016 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Buy | M | 0.99 | 5,051 | 5,000 | 41,414 | 36.4 K to 41.4 K (+13.89 %) |
| Dec 22 2016 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Buy | M | 1.24 | 36,363 | 45,090 | 36,363 | 0 to 36.4 K |
| Oct 31 2016 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | M | 0.25 | 18,181 | 4,545 | 0 | |
| Oct 31 2016 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Buy | M | 0.25 | 18,181 | 4,545 | 18,181 | 0 to 18.2 K |
| Jun 27 2016 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
| Jun 24 2016 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
| Jun 24 2016 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
| Jun 24 2016 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | A | 2.13 | 45,000 | 95,850 | 45,000 | |
| Jun 24 2016 | CNAT | Conatus Pharmaceut ... | Klassen Preston | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
| Jun 24 2016 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
| Apr 04 2016 | CNAT | Conatus Pharmaceut ... | Smith Edward F III | SVP, Reg Affairs an ... | Option Exercise | A | 2.53 | 100,000 | 253,000 | 100,000 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Option Exercise | A | 1.85 | 12,500 | 23,125 | 12,500 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Option Exercise | A | 1.85 | 50,000 | 92,500 | 50,000 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 1.85 | 21,875 | 40,469 | 21,875 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 1.85 | 109,375 | 202,344 | 109,375 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | A | 1.85 | 21,875 | 40,469 | 21,875 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | A | 1.85 | 109,375 | 202,344 | 109,375 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 1.85 | 37,500 | 69,375 | 37,500 | |
| Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 1.85 | 187,500 | 346,875 | 187,500 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | LACASSE LOUIS P | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | Klassen Preston | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | A | 5.52 | 35,000 | 193,200 | 35,000 | |
| Apr 10 2015 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Buy | P | 5.75 | 4,000 | 23,000 | 7,145 | 3.1 K to 7.1 K (+127.19 %) |
| Feb 25 2015 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Option Exercise | A | 6.40 | 50,000 | 320,000 | 50,000 | |
| Feb 25 2015 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | A | 6.40 | 100,000 | 640,000 | 100,000 | |
| Feb 25 2015 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 6.40 | 50,000 | 320,000 | 50,000 | |
| Feb 25 2015 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 6.40 | 150,000 | 960,000 | 150,000 | |
| Oct 03 2014 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 5.92 | 175,000 | 1,036,000 | 175,000 | |
| Jun 23 2014 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | A | 7.97 | 15,000 | 119,550 | 15,000 |